Does ENZALUTAMIDE Cause Dysstasia? 135 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 135 reports of Dysstasia have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.3% of all adverse event reports for ENZALUTAMIDE.
135
Reports of Dysstasia with ENZALUTAMIDE
0.3%
of all ENZALUTAMIDE reports
15
Deaths
43
Hospitalizations
How Dangerous Is Dysstasia From ENZALUTAMIDE?
Of the 135 reports, 15 (11.1%) resulted in death, 43 (31.9%) required hospitalization, and 2 (1.5%) were considered life-threatening.
Is Dysstasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 135 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Dysstasia?
ADALIMUMAB (1,181)
DALFAMPRIDINE (1,128)
METHOTREXATE (739)
SECUKINUMAB (637)
ETANERCEPT (602)
PREGABALIN (544)
CARBIDOPA\LEVODOPA (457)
PIMAVANSERIN (406)
TOFACITINIB (380)
DIMETHYL (352)
Which ENZALUTAMIDE Alternatives Have Lower Dysstasia Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE